Precision Lens: Private Flights for the Surgeons Choosing Its Lenses

The Precision Lens kickback verdict led to a $12 million settlement with the company and its former owner’s estate over benefits used to win surgeons’ business in Medicare-paid cataract surgery. The benefits included private-jet vacations and discounted frequent-flyer miles. Inside the business, a fund used to finance physician trips went by a revealing name: the secret fund.

Precision Lens distributes intraocular lenses and other ophthalmic supplies and equipment to surgeons and surgical facilities. Its customers’ product choices put those supplies into cataract procedures billed to Medicare. The Justice Department announced the settlement on July 25, 2024, following a civil jury verdict, an entered judgment and a reduction of that judgment.

A former Sightpath Medical vice president brought the qui tam case. Sightpath was a corporate partner of Precision Lens, and the government joined the whistleblower’s case.

What the Precision Lens Jury Found

On February 27, 2023, a federal civil jury found that Precision Lens and its owner violated the False Claims Act and the Anti-Kickback Statute by paying ophthalmic surgeons to induce their use of the company’s products. The Justice Department’s account of the verdict states that the conduct caused 64,575 false claims to Medicare.

That finding connected decisions made inside a distributor to bills submitted for patients’ operations. The surgeon received the benefit, chose the product and used it in a procedure for which Medicare paid. Taxpayers paid for health care influenced by the distributor’s benefits to surgeons.

What Are Some Examples of Kickbacks in Healthcare?

Precision Lens provided private-jet vacations and sold frequent-flyer miles at steep discounts to physicians whose product choices could send business its way. The benefits paid for recreation and cheaper travel for the surgeons selecting its supplies.

The trial announcement describes high-end skiing, fishing, golfing and hunting trips, along with sporting and entertainment vacations at exclusive destinations. Physicians traveled on private jets to see a Broadway musical in New York City, attend the College Football National Championship Game in Miami and visit the Masters Tournament in Augusta.

A distributor seeking cataract business was providing access to vacations and events far from the operating room. The surgeons got the travel benefits. Medicare paid the claims that the jury found those benefits had induced.

Discounted Miles Made the Benefit Look Like a Sale

The frequent-flyer arrangement gave physicians personal and business travel well below fair market value. A physician paid for the miles, but Precision Lens supplied them at a significant discount. The value lay in the favorable price.

That distinction matters inside a sales or accounting department. The transaction can appear as money coming into the company while still transferring a valuable benefit to the customer. Understanding the arrangement requires looking at what the customer received and the price charged for it together.

The 2020 Journal of Forensic and Investigative Accounting paper A Forensic Accountant’s Guide to the Most Potent Federal Laws Used Against Healthcare Fraud explains that kickback arrangements can involve indirect or noncash compensation for purchases and recommendations. Precision Lens makes that distinction tangible: the benefit could be built into a discounted sale of travel miles.

The Secret Fund and the Customer List

Precision Lens used a fund to finance physician trips, and its own employees called it a secret fund or slush fund. The government’s complaint announcement alleged that the money financed trips with key physician customers and sales targets. The later trial announcement said the United States proved that the fund furthered the kickback scheme.

The bookkeeping became part of the dispute. In the court’s January 2023 pretrial order, Precision Lens argued that the account held money belonging to Sightpath and appeared on its books as a liability. The court allowed evidence about the fund because its administration could show what Precision Lens knew and intended. Who held the account, who directed payments and whose customers benefited all mattered.

The whistleblower’s amended complaint adds an allegation about how invitees were chosen:

The alleged invitation list was a sales document. Surgery and referral volumes helped determine who received the trip. An insider familiar with those meetings could explain why a particular physician appeared on the list and how the company valued that relationship.

Why a Cataract Product Choice Reaches Medicare

A surgeon can strongly influence which device a facility buys, while the facility purchases it and bills for the procedure. That separation helps explain why a distributor would spend money on the physician making the choice.

The Department of Health and Human Services inspector general’s special fraud alert on physician-owned entities describes implantable devices as physician preference items. Both the brand and the type of device may be chosen or strongly influenced by the physician. The hospital or ambulatory surgery center is the institutional buyer, but its purchasing department may be responding to a clinical choice already made.

Medicare generally packages intraocular lenses into its payment for the outpatient procedure. The hospital’s procedure payment includes the device cost, and surgery centers likewise generally receive a packaged payment that includes the lens. The commercial sale of a lens and Medicare’s payment for an operation sit at different points in the same transaction.

That is why the Precision Lens story follows the surgery. The pretrial order addresses physicians’ choice of lens and viscoelastic brands, and evidence connecting the company’s products to particular procedures and the resulting Medicare claims. A supplier’s sales records identify what it sold. Patient medical records identify what was used. Medicare data identify the claims for the care.

The court also decided that damages in this case would measure the full amount Medicare paid for each false claim. It included both facility fees and professional fees in that approach. The cost of the lens alone did not set the government’s loss.

For a device insider, this is the commercial point behind the case. The physician’s choice can determine the distributor’s sale even though the physician, the purchasing facility and Medicare occupy different places in the payment chain. A benefit aimed at that choice can reach far beyond the supplier’s own invoice.

From the Precision Lens Kickback Verdict to the Settlement

The jury found $43,694,641 in damages to Medicare. The court then entered a judgment of $487,048,705 against Precision Lens and its owner, including three times the damages and civil penalties.

The trial announcement says statutory penalties were assessed per false claim. That explains why the judgment grew so far beyond the amount Medicare paid for the claims at issue.

The settlement announcement reports that, following post-trial motions, the court reduced the judgment to $216,675,248. The Justice Department then reviewed the defendants’ financial position and ability to satisfy the judgment. The July settlement followed that review and required an immediate payment by the company and the estate. Even after the court’s reduction, the settlement was a small fraction of the judgment.

In its settlement announcement, the Justice Department said the United States had collected nearly $27 million as a result of the misconduct alleged in the case. That total covered the wider matter, including earlier settlements with Sightpath Medical, TLC Vision Corporation, their former chief executive and a physician.

The Owner’s Conduct and the Estate’s Settlement

The civil jury found the Precision Lens owner personally liable, and the court entered judgment against him as well as the company. The trial announcement attributes the private-jet trips and discounted-mile transactions to the company and owner together.

The court’s account identifies the owner as the company’s founder and majority owner. The government’s complaint alleged his direct participation in transporting physicians to vacation destinations and selling them discounted miles. These were specific dealings with physician customers by a person at the top of the company.

The estate later joined Precision Lens in the settlement obligation.

What Evidence Is Needed to Report Fraud?

In a device kickback case, the useful evidence connects the physician’s benefit, the product choice and the Medicare claim. Precision Lens shows how travel arrangements, customer-selection records, fund accounting and surgery records can describe different parts of that connection.

The pretrial order describes proposed summary spreadsheets linking Medicare claims data to patient medical information identifying the products used in each surgery.

For someone in sales, the important knowledge may be why particular physicians were invited and what business the company expected from them. For someone handling the accounts, it may be the price charged for miles or the instructions behind a payment from the travel fund. For someone in a surgical facility, it may be the record showing which products were used in the procedures.

How Much Is a Whistleblower Claim Worth?

A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers. The Precision Lens case began through those whistleblower provisions, and the government joined the action against the company and its owner.

You Know Why the Physician Was Invited

If you saw physician travel chosen around sales targets, discounted miles or a fund paying for customer trips, speak with our whistleblower experts about why those physicians were chosen. We build your case with you, bring in medical device kickback whistleblower lawyers, and stay beside you as we turn your knowledge of those deals into your strongest case for recovery.